Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Mediated”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Testing effectiveness (Phase 2)WithdrawnNCT06050512
What this trial is testing

Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Kathleen Dorritie
Not applicableStudy completedNCT00357071
What this trial is testing

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

Who this might be right for
Eye Diseases
National Eye Institute (NEI) 219
Testing effectiveness (Phase 2)WithdrawnNCT01035593
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Who this might be right for
Graft RejectionKidney Transplantation
Pharming Technologies B.V.
Early research (Phase 1)Ended earlyNCT01848301
What this trial is testing

Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation

Who this might be right for
Cardiac Allograft VasculopathyAntibody Mediated Rejection
Gladwin, Mark, MD 12
Very early researchNot Yet RecruitingNCT07596680
What this trial is testing

CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusSystemic SclerosisANCA Associated Vasculitis+2 more
Nanjing Bioheng Biotech Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT02563340
What this trial is testing

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

Who this might be right for
Kidney Transplantation
First Affiliated Hospital, Sun Yat-Sen University 60
Testing effectiveness (Phase 2)UnknownNCT04492683
What this trial is testing

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children

Who this might be right for
Cow's Milk Allergy
DBV Technologies 230
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03571633
What this trial is testing

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

Who this might be right for
HER2-positive Breast CancerOperable Breast Cancer
Centre Leon Berard 90
Large-scale testing (Phase 3)Active Not RecruitingNCT06685757
What this trial is testing

Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
Biogen 132
Very early researchNot Yet RecruitingNCT07806045
What this trial is testing

Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement

Who this might be right for
IgG4 Related DiseaseSystemic Sclerosis (SSc)
Qiubai Li 18
Early research (Phase 1)Study completedNCT05456243
What this trial is testing

Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Mayo Clinic 8
Not applicableStudy completedNCT01981473
What this trial is testing

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Who this might be right for
Rheumatoid Arthritis
Pfizer 605
Testing effectiveness (Phase 2)Study completedNCT02474927
What this trial is testing

Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation

Who this might be right for
Lung Transplant Rejection
John F. McDyer, MD 22
Large-scale testing (Phase 3)Ended earlyNCT03744910
What this trial is testing

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
CSL Behring 194
Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Not applicableStudy completedNCT02147210
What this trial is testing

Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1

Who this might be right for
Kidney Transplantation
University Hospital, Toulouse 60
Not applicableLooking for participantsNCT07663669
What this trial is testing

Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated Rejection in Kidney Transplant
Centre Hospitalier Universitaire de Besancon 31
Not applicableUnknownNCT05779124
What this trial is testing

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

Who this might be right for
Kidney TransplantationKidney Transplant Rejection
First Affiliated Hospital, Sun Yat-Sen University 176
Next Page